Showing results (221-230 of 247) with videos related to
Sort By:
Pageof 25
The New England Journal of Medicine|October 9, 2014
Response and acquired resistance to everolimus in anaplastic thyroid cancerNikhil Wagle, Brian C Grabiner, Eliezer M Van Allen, et al.Nature Medicine|January 31, 2020
Author Correction: A human ciliopathy reveals essential functions for NEK10 in airway mucociliary clearanceRaghu R Chivukula, Daniel T Montoro, Hui Min Leung, et al.Cell Stem Cell|May 18, 2016
Mule Regulates the Intestinal Stem Cell Niche via the Wnt Pathway and Targets EphB3 for Proteasomal and Lysosomal DegradationCarmen Dominguez-Brauer, Zhenyue Hao, Andrew J Elia, et al.Science Advances|July 25, 2020
Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibitionAnne Fassl, Christopher Brain, Monther Abu-Remaileh, et al.Cancer Discovery|March 15, 2014
Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanibNikhil Wagle, Brian C Grabiner, Eliezer M Van Allen, et al.Nature Cancer|April 28, 2022
MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosisHamed Alborzinia, Andrés F Flórez, Sina Kreth, et al.Biorxiv : the Preprint Server for Biology|April 22, 2024
Ergothioneine boosts mitochondrial respiration and exercise performance via direct activation of MPSTHans-Georg Sprenger, Melanie J Mittenbühler, Yizhi Sun, et al.Cancer Research|February 26, 2013
Characterization of Torin2, an ATP-competitive inhibitor of mTOR, ATM, and ATRQingsong Liu, Chunxiao Xu, Sivapriya Kirubakaran, et al.Cancer Cell|July 4, 2009
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancerKrishna M Vasudevan, David A Barbie, Michael A Davies, et al.Biorxiv : the Preprint Server for Biology|October 3, 2025
Atlas of Lysosomal Aging Reveals a Molecular Clock of Storage Disorder-Associated MetabolitesAnna M Puszynska, Thao P Nguyen, Andrew L Cangelosi, et al.Pageof 25